semaglutide what to eat on what should i not eat

While medications approved for the treatment of type 2 diabetes have led to weight loss, they are not approved for off-label use, such as weight loss

Body composition testing reveals that many of these patients are losing significant skeletal muscle mass, effectively depleting their metabolic engines despite reaching a "normal" BMI

To get it approved, you would need to: Buy the patent (its for sale) Figure out a specific disease indication to apply for BPC-157 approval Hire a research team to run phase 1, 2, 3 trials The financial incentives make it so that BPC-157 will likely never go through the full FDA approval process, which is a shame given how promising this compound is

Any ethical missteps (e.g., accusations of hiding trial data, aggressive marketing beyond guidelines, environmental issues at factories) could hurt its reputation and invite regulatory penalties

Food and Drug Administration (FDA)-approved for the treatment of type 2 diabetes and for long-term weight management

Herdiana Y (2025) Bridging the Gap: The Role of Advanced Formulation Strategies in the Clinical Translation of Nanoparticle-Based Drug Delivery Systems